York Bridge Wealth Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

York Bridge Wealth Partners, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$446.73 - $548.2 $1.92 Million - $2.36 Million	-4,306 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$478.3 - $607.98 $102,356 - $130,107	214 Added 5.23%	4,306 $2.08 Million
Q3 2020 Oct 19, 2020	BUY	$544.75 - $658.21 $224,981 - $271,840	413 Added 11.23%	4,092 $2.29 Million
Q2 2020 Jul 20, 2020	BUY	$493.32 - $643.92 $258,993 - $338,058	525 Added 16.65%	3,679 $2.29 Million
Q1 2020 Apr 16, 2020	BUY	$336.18 - $494.43 $1,680 - $2,472	5 Added 0.16%	3,154 $1.54 Million
Q4 2019 Jan 17, 2020	SELL	$274.13 - $376.51 $23,575 - $32,379	-86 Reduced 2.66%	3,149 $1.18 Million
Q3 2019 Oct 21, 2019	BUY	$273.46 - $318.39 $76,295 - $88,830	279 Added 9.44%	3,235 $897,000
Q2 2019 Jul 18, 2019	BUY	$299.6 - $414.82 $8,388 - $11,614	28 Added 0.96%	2,956 $925,000
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $98,973 - $116,925	266 Added 9.99%	2,928 $1.2 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $87,313 - $104,790	-260 Reduced 8.9%	2,662 $994,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $9,480 - $11,029	27 Added 0.93%	2,922 $1.15 Million
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $100,463 - $121,781	353 Added 13.89%	2,895 $999,000
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $30,634 - $38,196	97 Added 3.97%	2,542 $826,000
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $6,455 - $8,459	18 Added 0.74%	2,445 $812,000
Q3 2017 Oct 27, 2017	SELL	$431.38 - $504.0 $175,140 - $204,624	-406 Reduced 14.33%	2,427 $1.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,833	2,833 $1.38 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.